Hypoglycemia2

•Download as PPT, PDF•

3 likes•761 views

This presentation was present by my friend during emergency posting seminar with Dr.Mohd. Kamal Mohd. Arshad. I upload this ppt here for all of us and my own reference too. Good luck in your life.

Hypoglycemia NASRUDDIN BIN ABDUL RAHMAN 2006832992

Investigation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Management ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Prevention is better than cure!! ,[object Object],[object Object],[object Object],[object Object]

What's hot

Pediatric Hypoglycemia

LWCH, UAE

DIABETIC KETO ACIDOSIS

Aliya Emil

Hyper hypoglycaemia

Karina Araújo

disorders of Carbohydrate metabolism

IRAMIQBAL12

Hypoglycemia

Karen Jie Ren

Diabetes mellitus type ii

Iqra Butt

Hypoglycemiapcerny

Hypoglycemia in dm patients

Mohammad Othman Daoud

HypoglycemiaBandihado

Hypoglycemia

blue bird

Hypoglycemia in children

Sujay Bhirud

Hypoglycemia in children

ravindrabn4

Diabetic emergency

Soe Myat Thwe

Diabetic pt mg

Sonam Yeshi

Endocrine System Disorders

Mayur Gaikar

Diabetic emergenciesdrsajjadp

Diabetes mellitus

Aliya Emil

Hypoglycemia in Adults

Dr Shumayla Aslam-Faiz

Module 3 blood sugarjanmacmann

Dka management in children

Abdulmoein AlAgha

What's hot (20)

Pediatric Hypoglycemia

DIABETIC KETO ACIDOSIS

Hyper hypoglycaemia

disorders of Carbohydrate metabolism

Hypoglycemia

Diabetes mellitus type ii

Hypoglycemia

Hypoglycemia in dm patients

Hypoglycemia

Hypoglycemia in children

Diabetic emergency

Diabetic pt mg

Endocrine System Disorders

Diabetic emergencies

Diabetes mellitus

Hypoglycemia in Adults

Module 3 blood sugar

Dka management in children

Similar to Hypoglycemia2

Type 1 Diabetes MellitusJaymax13

DIABETES

KAVITHAPATNAIK13691

Endocrine emergenciesDr. Rubz

Endocrine emergencies

Mohd Hanafi

Antidiabetic Drugs.ppt pharmacy students

FranciKaySichu

Hypoglycemia

yuyuricci

Diabetes.pdf

JustinMutua

Metabolic-Emergencies.pptx

WengelRedkiss

Classification And Diagnosis Of DiabetesPeninsulaEndocrine

diabetes & perio

neeti shinde

Diabetes Part 2pbradley323

diabetes mellitus and insulin docum pptx

jerriecesar

#Diabetes mellitus disease ppt presentation

rk17602629

Diabetes s11mjpol

Diabetes MellitusTosca Torres

Diabetes Mellitusmohammed sediq

Diabetes Mellitus management in OPDnium

Complications of diabetes melitus

ANILKUMAR BR

Diabetes mellitus (DM) has routinely been described as a metabolic disorder characterized by hyperglycemia that develops as a consequence of defects in insulin secretion, insulin action, or both. Such a deficiency results in increased concentrations of glucose in the blood, which in turn damage many of the body's systems, in particular the blood vessels and nerves. 1. Microvascular (due to damage to small blood vessels). 2. Macrovascular (due to damage to larger blood vessels).

Hypoglycaemia Biochemistry decrease in Glucose mechanism

MirzaNaadir

Diabetes mellitus and D inspidus

Kanwarpal Dhillon

Similar to Hypoglycemia2 (20)

Type 1 Diabetes Mellitus

DIABETES

Endocrine emergencies

Antidiabetic Drugs.ppt pharmacy students

Hypoglycemia

Diabetes.pdf

Metabolic-Emergencies.pptx

Classification And Diagnosis Of Diabetes

diabetes & perio

Diabetes Part 2

diabetes mellitus and insulin docum pptx

#Diabetes mellitus disease ppt presentation

Diabetes s11

Diabetes Mellitus

Diabetes Mellitus management in OPD

Complications of diabetes melitus

Hypoglycaemia Biochemistry decrease in Glucose mechanism

Diabetes mellitus and D inspidus

Recently uploaded

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...

kevinkariuki227

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Anujkumaranit

ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND

DR SETH JOTHAM

Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum. There are a number of conditions that present acutely, predominantly with pain and/or swelling A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle. Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction. The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent

POST OPERATIVE OLIGURIA and its management

touseefaziz1

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

DR SETH JOTHAM

The prostate is an exocrine gland of the male mammalian reproductive system It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ). It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes It’s work is regulated by androgens which are responsible for male sex characteristics Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

bkling

Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

Savita Shen $i11

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

Cervical & Brachial Plexus By Dr. RIG.pptx

Dr. Rabia Inam Gandapore

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

263778731218 Abortion Clinic /Pills In Harare ,

sisternakatoto

263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/

24 Upakrama.pptx class ppt useful in all

DrSathishMS1

New Drug Discovery and Development .....

NEHA GUPTA

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND

POST OPERATIVE OLIGURIA and its management

Ophthalmology Clinical Tests for OSCE exam

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Cervical & Brachial Plexus By Dr. RIG.pptx

basicmodesofventilation2022-220313203758.pdf

263778731218 Abortion Clinic /Pills In Harare ,

24 Upakrama.pptx class ppt useful in all

New Drug Discovery and Development .....

micro teaching on communication m.sc nursing.pdf

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Evaluation of antidepressant activity of clitoris ternatea in animals

Physiology of Chemical Sensation of smell.pdf

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Hypoglycemia2

1. Hypoglycemia NASRUDDIN BIN ABDUL RAHMAN 2006832992

Hypoglycemia2

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Hypoglycemia2

Similar to Hypoglycemia2 (20)

More from Home~^^

More from Home~^^ (13)

Recently uploaded

Recently uploaded (20)

Hypoglycemia2